Comment on Utsumi et al. Differences in Pathophysiology and Treatment Efficacy Based on Heterogeneous Out-of-Hospital

Raghuraman M Sethuraman1, Buddhan Rajarathinam2, Pranjali Kurhekar1

  • 1Department of Anesthesiology, Sree Balaji Medical College & Hospital, BIHER, Chennai 600044, India.

PubMed

Insights

This commentary addresses neuron-specific enolase (NSE) thresholds in out-of-hospital cardiac arrest (OHCA) patients. It clarifies NSE values based on initial rhythm and corrects reference misquotations in a recent review.

Area of Science:

  • Neurology
  • Cardiology
  • Biochemistry

Background:

  • The review article discussed pathophysiology and treatment for out-of-hospital cardiac arrest (OHCA) patients.
  • Neuron-specific enolase (NSE) is a biomarker used in assessing neurological damage post-cardiac arrest.

Discussion:

  • This commentary focuses on the threshold values for neuron-specific enolase (NSE).
  • It specifically examines how initial cardiac rhythm influences NSE levels in OHCA patients.
  • The authors also identify and correct misquoted references within the reviewed article.

Key Insights:

  • Initial cardiac rhythm is a critical factor influencing neuron-specific enolase (NSE) threshold values in OHCA.
  • Accurate interpretation of NSE requires consideration of the specific presenting rhythm.
  • Correction of reference misquotations is essential for the integrity of scientific literature.

Outlook:

  • Further research may refine NSE thresholds based on detailed rhythm analysis in OHCA.
  • Standardizing NSE interpretation guidelines will improve patient prognostication.
  • Ensuring accurate citation practices is vital for advancing scientific understanding in critical care.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...